human gecko v2 pooled sgrna library 185 (Addgene inc)
Addgene inc is a verified supplier 
96
Structured Review
Addgene inc
human gecko v2 pooled sgrna library 185
Human Gecko V2 Pooled Sgrna Library 185, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 6137 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+gecko+v2+pooled+sgrna+library+185/lentiCRISPR+v2+(Plasmid+%2352961)/pm41392282-68-16-23
Average 96 stars, based on 6137 article reviews
Human Gecko V2 Pooled Sgrna Library 185, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 6137 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+gecko+v2+pooled+sgrna+library+185/lentiCRISPR+v2+(Plasmid+%2352961)/pm41392282-68-16-23
Average 96 stars, based on 6137 article reviews
human gecko v2 pooled sgrna library 185 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Genome Wide:Article Title: Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair. Article Snippet: .. 182 Genome-Wide CRISPR-Cas9 Knockout Screening 183 A genome-wide CRISPR-Cas9 loss-of-function screen was 184 performed using the CRISPR:Article Title: Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair. Article Snippet: .. 182 Genome-Wide CRISPR-Cas9 Knockout Screening 183 A genome-wide CRISPR-Cas9 loss-of-function screen was 184 performed using the Knock-Out:Article Title: Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair. Article Snippet: .. 182 Genome-Wide CRISPR-Cas9 Knockout Screening 183 A genome-wide CRISPR-Cas9 loss-of-function screen was 184 performed using the Construct:Article Title: Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair. Article Snippet: .. 182 Genome-Wide CRISPR-Cas9 Knockout Screening 183 A genome-wide CRISPR-Cas9 loss-of-function screen was 184 performed using the |